Atrial Fibrillation: In Search for the Optimal Target for Rate Control
NCT07135258
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Atrial Fibrillation (Permanent)
Atrial Fibrillation (AF)
Interventions
DRUG:
Ivabradine + Usual Care
DRUG:
Placebo + usual care
Sponsor
The University of Hong Kong